Case of cutaneous malignant melanoma surviving 16 years with late recurrence

Journal of Dermatology

Volumn 36, Issue 11, 2009, Pages 598-603

  Otsu, Utako ^a   Fukui, Nao ^a   Iki, Mariko ^a   Moriwaki, Shinichi ^a   Kiyokane, Kimihiro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

interferon; In transit metastasis; Late recurrence; Malignant melanoma

Indexed keywords

BETA INTERFERON; DACARBAZINE; NIMUSTINE; VINCRISTINE;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; EXCISION; FEMALE; FOOT; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; IN-TRANSIT METASTASIS; INGUINAL LYMPH NODE; LYMPH NODE DISSECTION; MELANOMA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; SCAR; SCINTIGRAPHY; SKIN METASTASIS; SKIN NODULE; TUMOR VOLUME;

BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; FOOT; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRALESIONAL; INTERFERONS; JAPAN; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 70350624769     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2009.00719.x     Document Type: Article

References (14)

1. Wilbur DL, Harman HR. Malignant melanoma with delayed metastatic growths. Ann Intern Med 1931 5 : 201 211.
2. Callaway MP, Briggs JC. The incidence of late recurrence (greater than 10 years): an analysis of 536 consecutive case of cutaneous melanoma. Br J Plast Surg 1989 42 : 46 49.
3. Briele HA, Beattie CW, Ronan SG, Chaudhuri PK, Das Gupta TK. Late recurrence of cutaneous melanoma. Arch Surg 1983 118 : 800 803.
4. Schmid-Wendtner MH, Baumert J, Schmidt M et al. Late metastases of cutaneous melanoma: an analysis of 31 patients. J Am Acad Dermatol 2000 43 : 605 609.
5. Crowley NJ, Seigler HF. Late recurrence of malignant melanoma: analysis of 168 patients. Ann Surg 1990 212 : 173 177.
6. Shaw HM, Beattie CW, McCarthy WM, Milton GW. Late relapse from cutaneous stage I malignant melanoma. Arch Surg 1985 120 : 1155 1159.
7. Johns TG, Mackay IR, Callister KA, Hertzog PJ, Devenish RJ, Linnane AW. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon-β. J Natl Cancer Inst 1992 84 : 1185 1190.
8. Horikoshi T, Fukazawa K, Hanada N et al. In vitro comparative study of the antitumor effects of human interferon-α, β and γ on the growth and invasive potential of human melanoma cells. J Dermatol 1995 22 : 631 636.
9. McCarty MF, Bielenberg D, Donawho C et al. Evidence for the causal of endogenous interferon-α/β in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms. Clin Exp Metastasis 2002 19 : 609 615.
10. Singh RK, Gutman M, Llansa N, Fidler IJ. Interferon-β prevents the upregulation of interlrukin-8 express in human melanoma cells. J Interferon Cytokine Res 1996 16 : 577 584.
11. Takaoka A, Taniguchi T. New aspects of IFN-α/β signaling in immunity, oncogenesis and bone metabolism. Cancer Sci 2003 94 : 405 411.
12. Yamamoto A, Sumi A, Kato Y et al. [Transfer of interferon-β to lymphatic vessels, injected around the melanoma lesions]. Skin cancer 1986 1 : 47 53 (In Japanese).
13. Hayes AJ, Clark MA, Harries M, Thomas JM. Management of in-transit metastases from cutaneous malignant melanoma. Br J Surg 2004 91 : 673 682.
14. Hanson C, Köpf I, Weijdegård B, Weimarck A, Stierner U. Sensitivity to extrinsically supplied interferon and the endogenous expression of interferon in melanoma cell lines. Melanoma Res 1999 9 : 451 456.